Fennec Pharmaceuticals Inc.

IPO

Hearing Loss in Chemotherapy | Pedmark | Fennec Pharmaceuticals

Public · Durham, United States · Founded 1996 · $47.9M raised

Employees
1–10
Founded
1996
Business Model
B2B
Total Funding
$47.9M
Last Round
$40.3M Corporate RoundNov 2025
Rounds
2
Type
Public

About

Fennec Pharmaceuticals is a commercial-stage specialty pharma company focused on PEDMARK, a therapy to reduce chemotherapy-induced hearing loss in children.

Summary

Fennec Pharmaceuticals Inc. is a Biotech company based in Durham, United States, founded in 1996. It has raised $47.9M in total across 2 rounds, most recently a $40.3M Corporate Round round in Nov 2025. Investors include Piper Sandler and Craig-Hallum Capital Group.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Corporate RoundCorporate RoundNov 2025
$40.3M

Sign up to see all 3 rounds

IPO through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Fennec Pharmaceuticals Inc. on Indexed.vc
<a href="https://indexed.vc/companies/fennec-pharmaceuticals-inc"><img src="https://indexed.vc/api/badge/company/fennec-pharmaceuticals-inc" alt="Fennec Pharmaceuticals Inc. on Indexed.vc" width="260" height="76" /></a>